Human Umbilical Cord Mesenchymal Stromal Cells Support Viability of Umbilical Cord Blood Hematopoietic Stem Cells but not the “Stemness” of Their Progeny in Co-Culture

被引:0
作者
Yu. A. Romanov
N. E. Volgina
E. E. Balashova
N. V. Kabaeva
T. N. Dugina
G. T. Sukhikh
机构
[1] Ministry of Health of the Russian Federation,Russian Cardiology Research
[2] V. I. Kulakov Research Center of Obstetrics,and
[3] Gynecology,Production Complex
[4] and Perinatology,undefined
[5] Ministry of Health of the Russian Federation,undefined
[6] CryoCenter Cord Blood Bank,undefined
来源
Bulletin of Experimental Biology and Medicine | 2017年 / 163卷
关键词
mesenchymal stromal cells; umbilical cord; hematopoietic stem cells; umbilical cord blood; co-culturing;
D O I
暂无
中图分类号
学科分类号
摘要
Cell—cell interactions and the ability of mesenchymal stromal cells to support the expansion of hematopoietic progenitor cells were studied in co-culture of human umbilical cord tissue-derived mesenchymal stromal cells and nucleated umbilical cord blood cells. It was found that hematopoietic stem cells from the umbilical cord blood are capable to adhere to mesenchymal stromal cells and proliferate during 3-4 weeks in co-culture. However, despite the formation of hematopoietic foci and accumulation of CD34+ and CD133+ cells in the adherent cell fraction, the ability of newly generated blood cells to form colonies in semi-solid culture medium was appreciably reduced. These findings suggest that human umbilical cord tissue-derived mesenchymal stromal cells display a weak capability to support the “stemness” of hematopoietic stem cell progeny despite long-term maintenance of their viability and proliferation.
引用
收藏
页码:523 / 527
页数:4
相关论文
共 112 条
[1]  
Bai L(2016)Bioactive molecules derived from umbilical cord mesenchymal stem cells Acta Histochem. 118 761-769
[2]  
Li D(2013)Umbilical cord blood transplantation: the first 25 years and beyond Blood. 122 491-498
[3]  
Li J(2016)Is there any reason to prefer cord blood instead of adult donors for hematopoietic stem cell transplants? Front. Med. (Lausanne) 2 95-103
[4]  
Luo Z(2010)Umbilical cord transplantation: epilogue Semin. Hematol. 47 97-838
[5]  
Yu S(2013)Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine Stem Cells Transl. Med. 2 830-1178
[6]  
Cao S(1989)Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling N. Engl. J. Med. 26 1174-454
[7]  
Shen L(2009)Cord blood transplantation: state of the art Haematologica. 94 451-589
[8]  
Zuo Z(2014)Enrichment of umbilical cord blood mononuclears with hemopoietic precursors in co-culture with mesenchymal stromal cells from human adipose tissue Bull. Exp. Biol. Med. 156 584-1083
[9]  
Ma X(2013)Cord blood transplantation: can we make it better? Front. Oncol. 3 238-527
[10]  
Ballen KK(2016)Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: A proteomic analysis Stem Cells Dev. 25 1073-574